Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Treatment-naive, discontinued the previous treatment course of etoricoxib or celecoxib at least 3 months previously or currently receiving continuous treatment with oral etoricoxib or celecoxib~* Consent to take part in the study~* Included in his/her physician's client base for at least 1 year~Exclusion Criteria:~* Unable to receive follow-up over a year~* Included in an interventional trial

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group Arcoxia® (Type: None): Participants who were either previously treated with Arcoxia® or initiated on study treatment with Arcoxia®. Participant data in terms of dosage, treatment duration, and reasons for prescription was collected under actual conditions of use.
- Group Celebrex® (Type: None): Participants who were either previously treated with Celebrex® or initiated on study treatment with Celebrex®. Participant data in terms of dosage, treatment duration, and reasons for prescription was collected under actual conditions of use.

Based on this trial design, predict the completion outcome and termination type (if applicable).